Valuation: Carvolix

Market Cap 37Cr 33Cr 30Cr 28Cr 52Cr 3.6TCr 53Cr 361.45Cr 141.69Cr 1.76TCr 140.1Cr 137.04Cr 6.07TCr P/E 2025 *
-12.5x
P/E 2026 * -12x
Enterprise Value 40Cr 35Cr 32Cr 30Cr 56Cr 3.87TCr 57Cr 388.39Cr 152.25Cr 1.89TCr 150.54Cr 147.26Cr 6.52TCr EV / Sales 2025
-
EV / Sales 2026 * 269x
Free-Float
25.37%
Yield 2025 *
-
Yield 2026 * -
1 day-8.61%
1 week-22.91%
Current month+59.54%
1 month+55.93%
3 months+79.22%
6 months+204.97%
Current year+219.08%
1 week 5.4
Extreme 5.4
6.7
1 month 3.21
Extreme 3.21
7.56
Current year 1.73
Extreme 1.73
7.56
1 year 1.18
Extreme 1.18
7.56
3 years 0.93
Extreme 0.93
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap.
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 14,19,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
-8.61%-22.91%+338.10%+377.92% 41Cr
-0.10%-0.29%+38.04%+3.97% 1.25TCr
-0.22%+10.37%+15.54%+20.68% 657Cr
-0.28%-2.12%+59.03%+26.88% 583.23Cr
-0.06%+5.09% - - 475.47Cr
+7.86%+6.28%-24.06%+26.14% 425.11Cr
+1.80%+5.55%-20.95%-20.32% 401.74Cr
+0.13%-0.93%-0.50%-58.70% 184.39Cr
-1.63%-5.33%-6.07%+253.63% 180.49Cr
+1.15%+2.49%+61.94%-2.06% 156Cr
Average +0.00%-0.37%+51.23%+69.79% 435.64Cr
Weighted average by Cap. +0.73%+2.75%+24.72%+22.49%

Financials

2025 2026 *
Net sales - 15.83L 13.87L 12.83L 11.8L 22.26L 15Cr 22.61L 1.53Cr 60.12L 7.47Cr 59.44L 58.15L 26Cr
Net income -2.21Cr -1.94Cr -1.79Cr -1.65Cr -3.1Cr -212.96Cr -3.15Cr -21Cr -8.39Cr -104.2Cr -8.29Cr -8.11Cr -359Cr -3.31Cr -2.9Cr -2.68Cr -2.47Cr -4.66Cr -319.52Cr -4.73Cr -32Cr -13Cr -156.34Cr -12Cr -12Cr -538.63Cr
Net Debt 2.78Cr 2.44Cr 2.25Cr 2.07Cr 3.91Cr 268.14Cr 3.97Cr 27Cr 11Cr 131.2Cr 10Cr 10Cr 452.01Cr 5.27Cr 4.62Cr 4.27Cr 3.93Cr 7.41Cr 508.09Cr 7.53Cr 51Cr 20Cr 248.6Cr 20Cr 19Cr 856.52Cr
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
76
Date Price Change Volume
20/26/20 €5.520 -8.61% 53,509
17/26/17 €6.040 +7.86% 42,155
16/26/16 €5.600 -11.95% 49,864
15/26/15 €6.360 -0.63% 92,826
14/26/14 €6.400 -10.61% 88,547
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.520EUR
Average target price
5.033EUR
Spread / Average Target
-8.82%

Annual profits - Rate of surprise